General Principles - The purpose of the fundraising management system is to standardize the management of funds raised by the company, improve the efficiency and effectiveness of fund usage, and protect the interests of investors [1][2] - The funds raised refer to the money obtained by the company through the issuance of stocks and their derivatives for specific purposes [1] Fund Storage - The company must prudently select commercial banks and open special accounts for the raised funds, which should not be stored in the group's financial company [2][3] - A tripartite supervision agreement must be signed with the sponsor or independent financial advisor and the commercial bank within one month of the funds being received [3][4] Fund Usage - The usage of raised funds must strictly follow the approval and decision-making procedures outlined in the system and relevant regulations [4][5] - The company must ensure that the use of funds aligns with the commitments made in the issuance application documents and must not change the direction of fund usage arbitrarily [5][6] Project Feasibility - The board of directors must fully verify the feasibility of fundraising projects, ensuring they have good market prospects and profitability [6][7] - Funds raised should primarily be used for the main business, and certain behaviors, such as financial investments or providing funds to controlling shareholders, are prohibited [7][8] Changes in Fund Usage - Any changes in the use of raised funds must be approved by the board of directors and disclosed in a timely manner [8][9] - If a project is completed, any surplus funds must be used for other fundraising projects with board approval [10][11] Continuous Supervision - The finance department must maintain a ledger of the usage of raised funds, and the audit department must check the storage and usage at least every six months [12][13] - The board of directors must continuously monitor the actual management and usage of raised funds and disclose the situation accurately [14][15]

Fundraising Overview - The company has raised a total of RMB 2,529,664,782.94 through a non-public offering of 23,694,480 shares, approved by the China Securities Regulatory Commission [1] - The funds will be primarily used for the manufacturing project of high-end flip chip IC substrates, with a total investment of RMB 276,627,000 and planned fundraising of RMB 255,000,000 [1] Change of Project Implementation Entity - The company has approved a change in the project implementation entity for the high-end flip chip IC substrate manufacturing project from its wholly-owned subsidiary Wuxi Shennan to another wholly-owned subsidiary, Wuxi Guangxin Packaging Substrate Co., Ltd. [2] Fund Management and Storage - The company has revised its fundraising management system to ensure dedicated storage and usage of the raised funds, in compliance with relevant laws and regulations [2] - The management system includes provisions for fund storage, usage, project management, and supervision of investment projects [2] Fund Supervision Agreements - The company has signed tripartite and quadripartite supervision agreements with banks and underwriters to ensure proper management of the raised funds [3] - A new quadripartite supervision agreement was signed following the change of the project implementation entity [3] Fund Account Status - The company has closed several fundraising accounts, including those at China Bank and Agricultural Bank, as part of its fund management strategy [5] - The company has transferred RMB 54,764,800 from one of its fundraising accounts to its own funds and completed the account closure [6]

Core Viewpoint - Anhui Huaren Health Pharmaceutical Co., Ltd. plans to use up to 100 million yuan of idle raised funds to temporarily supplement working capital, ensuring that it does not affect the construction of fundraising projects and the normal use of raised funds [1][4][5] Summary by Sections Fundraising Basic Information - The company has issued 60.01 million shares at a price of 16.24 yuan per share, raising a total of approximately 974.56 million yuan, with a net amount of 879.45 million yuan after deducting issuance costs [1][2] Fundraising Investment Project Overview - The total investment amount for the fundraising projects is 605.68 million yuan, with the entire amount allocated from the raised funds [2] - The company has decided to change part of the fundraising purpose, allocating 45 million yuan for the "Marketing Network Construction Project" and for acquiring 60% of the shares of Zhoushan Likang Pharmaceutical Chain Co., Ltd. [2] Previous Use of Idle Funds - The company previously used 150 million yuan of idle funds to supplement working capital, which has been fully returned to the fundraising account by May 8, 2025 [4] Current Use of Idle Funds - The company plans to use up to 100 million yuan of idle funds for working capital, with a usage period not exceeding 12 months from the board's approval date [4][5] - The use of these funds is limited to operations related to the main business and cannot be used for stock trading or other financial instruments [5] Necessity and Reasonableness - The decision to use idle funds is aimed at improving fund efficiency, reducing financial costs, and supporting the company's operational needs, thereby enhancing its competitive position in the pharmaceutical health sector [5][6] Review Procedures and Opinions - The board of directors, supervisory board, and independent directors have all approved the use of idle funds, confirming that the process complies with relevant regulations and does not affect the implementation of fundraising projects [6][7]

二、监事会会议审议情况 本次会议审议并通过如下议案： 经审议，监事会认为：董事会审议本次变更募集资金用途的程序符合《上市 公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》等中国证监 会和深圳证券交易所规范性文件及公司《公司章程》《募集资金管理制度》等的 相关规定，公司本次变更部分募集资金用途事项，符合公司当前实际和发展需要， 有利于提高募集资金使用效率和长远利益，符合公司及全体股东的利益，不存在 损害公司、投资者特别是中小投资者利益的情形。 本议案尚需提交股东大会审议。 证券代码：301408 证券简称：华人健康 公告编号：2025-041 安徽华人健康医药股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 安徽华人健康医药股份有限公司（以下简称"公司"）第五届监事会第八次 会议已于 2025 年 5 月 16 日以书面、邮件送达形式发出通知，并于 2025 年 5 月 合相关法律法规及《公司章程》的规定，做出的决议合法有效。 经审议，监事会认为：本次使用闲置募集资金临时补充流动资金的审议程序 符合《上市公司监 ...

Core Viewpoint - The company Jiangxi Mubang High-Tech Co., Ltd. has had part of its fundraising account frozen due to legal actions, which may impact its operational and investment projects [2][4]. Group 1: Basic Situation - The company has opened fundraising accounts at several banks, including Ganzhou Bank, Beijing Bank, China Everbright Bank, and Citic Bank, where funds have been judicially frozen [2][3]. - As of May 15, 2025, the total amount frozen across these accounts is 34.89 million yuan, with specific accounts showing varying amounts frozen [3][4]. Group 2: Reasons for Judicial Freezing - The freezing of funds is primarily due to lawsuits involving Jiangxi Chantuo Commercial Factoring Co., Ltd. and other companies, stemming from a failure to make timely payments related to a domestic factoring contract [4]. Group 3: Impact on the Company - As of May 15, 2025, the remaining balance in the company's fundraising accounts is 132.36 million yuan, with 97.47 million yuan available for use after accounting for the frozen funds [4]. - Other than the five accounts that are frozen, the remaining fundraising accounts are operational and can be used normally [4].

四川港通医疗设备集团股份有限公司 第一章 总则 第一条 为规范四川港通医疗设备集团股份有限公司（以下简称公司）募 集资金管理，提高募集资金的使用效率，根据《中华人民共和国公司法》《中华 人民共和国证券法》《上市公司募集资金监管规则》《深圳证券交易所创业板股 票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公 司规范运作》等相关法律法规、规范性文件以及《四川港通医疗设备集团股份有 限公司章程》（以下简称《公司章程》）的规定，制定本制度。 第二条 本制度所称募集资金是指公司通过发行股票或者其他具有股权 性质的证券，向投资者募集并用于特定用途的资金，但不包括公司实施股权激励 计划募集的资金。 第三条 公司募集资金应当专款专用。公司使用募集资金应当符合国家产 业政策和相关法律法规，践行可持续发展理念，履行社会责任，原则上应当用于 主营业务，有利于增强公司竞争能力和创新能力。 第四条 公司董事会应当持续关注募集资金存放、管理和使用情况，有效 防范投资风险，提高募集资金使用效益。 第五条 公司的董事、高级管理人员应当勤勉尽责，督促公司规范使用募 集资金，确保公司募集资金安全，不得操控公司擅自或变相 ...

山高环能集团股份有限公司（以下简称"公司"）2024 年 7 月 3 日召开第十 一届董事会第十三次会议及第十一届监事会第九次会议，审议通过了《关于使用 部分闲置募集资金暂时补充流动资金的议案》，同意公司使用部分闲置募集资金 人民币 3,315.00 万元暂时补充流动资金，用于主营业务相关的生产经营使用，使 用期限自董事会审议批准该议案之日起不超过 12 个月。具体详见公司于 2024 年 7 月 4 日在《中国证券报》《上海证券报》《证券时报》及巨潮资讯网 （www.cninfo.com.cn）披露的《关于使用部分闲置募集资金暂时补充流动资金 的公告》（公告编号：2024-047）。 根据上述决议，公司在使用部分闲置募集资金暂时补充流动资金期间，对资 金进行了合理的安排与使用，资金运用情况良好。 前归还至募集资金专用账户。截至本公告披露日，公司已归还募集资金 2,250 万 元，并及时将上述募集资金的归还情况通知了保荐机构和保荐代表人，其余用于 临时补充流动资金的 1,065 万元募集资金将在到期日之前归还。 特此公告。 证券代码：000803 证券简称：山高环能 公告编号：2025-027 山高环能集团股 ...

Core Viewpoint - The company plans to temporarily use idle raised funds to supplement working capital, amounting to no more than 180 million yuan, for a period not exceeding 12 months, without affecting the normal implementation of fundraising projects [1][2]. Group 1 - The temporary use of idle raised funds is aimed at improving the efficiency of fund utilization and reducing financial costs [2]. - The decision complies with relevant regulations from the China Securities Regulatory Commission and the Shanghai Stock Exchange [2]. - The company assures that this action will not change the purpose of the raised funds or harm the interests of shareholders, especially minority shareholders [2].

Core Points - The company has approved the establishment of a special account for raised funds to enhance the management and usage of the funds [1][5] - The total amount raised from the issuance of convertible bonds is 243 million yuan, with net proceeds of approximately 240.91 million yuan after deducting underwriting fees [1][2] - The funds will be used for the construction of a new high-end energy-saving fan project [4][5] Fundraising Overview - The company issued 2.43 million convertible bonds at a price of 100 yuan each, approved by the China Securities Regulatory Commission [1] - The funds were fully received by October 23, 2023, and verified by an accounting firm [2] Fund Management and Supervision - A tripartite supervision agreement has been signed among the company, its subsidiary, and the bank to regulate the management of the raised funds [3][5] - The special account will be used exclusively for the new high-end energy-saving fan project, ensuring that funds are not diverted for other purposes [5][6] Board and Supervisory Opinions - The board of directors and the supervisory board have both approved the establishment of the special account, emphasizing that it will improve efficiency and protect the interests of all shareholders, especially minority shareholders [9][10]

Fundraising Overview - The company Shanghai Nanchip Semiconductor Technology Co., Ltd. has been approved to publicly issue 63.53 million shares at a price of RMB 39.99 per share, raising a total of RMB 2.54 billion [1] - As of December 31, 2024, the balance in the fundraising special account was RMB 438,595,817.81, including interest income after deducting handling fees [1] Fund Management and Usage - The company has signed a tripartite supervision agreement for the special fundraising account with the sponsoring institution and the commercial bank where the funds are stored [2][3] - The original fundraising project "Testing Center Construction Project" has been changed to "Chip Testing Industrial Park Construction Project" to enhance operational efficiency [2] - A wholly-owned subsidiary, Zhejiang Nanchip Semiconductor Co., Ltd., has been established as the implementation entity for the new fundraising project [2] Tripartite Supervision Agreement - The tripartite supervision agreement involves the company, Shanghai Pudong Development Bank, and CITIC Securities, ensuring that the funds are used solely for the designated projects [4][5] - The agreement stipulates that the company must notify the sponsoring institution of any withdrawals exceeding RMB 50 million or 20% of the net fundraising amount within 12 months [7][17] - The sponsoring institution is responsible for supervising the use of the funds and must conduct at least one on-site investigation every six months [11][16] Account Management - The special account has been opened for the chip testing industrial park construction project, and the funds must not be used for other purposes [4][13] - Monthly account statements will be provided to the company, and any discrepancies must be reported to the Shanghai Stock Exchange [7][12] - The agreement will remain in effect until all funds are fully utilized and the account is closed [8][18]